ReviewPharmaceutics2023

Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand.

Vladimir Temchura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.